Mylan Is Done Leaning on EpiPen Sales and That Could be a Big Problem

Mylan Is Done Leaning on EpiPen Sales and That Could be a Big Problem

4 Stocks for Fighting Zika

4 Stocks for Fighting Zika

Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny

Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny

Amgen's Shameful Silence Covers Up Reasons for FDA Drug Rejection

Amgen's Shameful Silence Covers Up Reasons for FDA Drug Rejection

Futures Lower Following Clinton EpiPen Tweet; Asia Opens Down Too

Futures Lower Following Clinton EpiPen Tweet; Asia Opens Down Too

Gilead Sciences Shares Slide on Leerink Price Target Cut

Gilead Sciences Shares Slide on Leerink Price Target Cut

Mylan Falls After Being Called Out on Price Increases -- Should You Worry?

Mylan Falls After Being Called Out on Price Increases -- Should You Worry?

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business
Why Pfizer's Latest Deal Could Send Its Shares Soaring

Why Pfizer's Latest Deal Could Send Its Shares Soaring

Earthquake in Central Italy Keeps Markets Cautious, Dozens Killed

Earthquake in Central Italy Keeps Markets Cautious, Dozens Killed